Espicom market intelligence, brought to you by Business Monitor InternationalTHE PHARMACEUTICAL MARKET: GREECE - REVIEWThe immediate threat of a Greek default and eurozone exit was reduced as the outcome of the legislative elections in June had a much more benign outcome than many feared. A n exit would have - and could still be - disastrous for drugmakers operating in the market. But even Greece staying in the monetary union means the government must continue with its austerity programme. While we continue to hold to our view that Germany and the rest of the EU may reduce the focus on austerity and introduce some pro-growth strategies, these are unlikely to generate any upside for the pharmaceutical industry and structural reforms within Greece will be maintained. T he government remains committed to huge cuts in its public drug expenditure for 2012, with a painful claw-back tax in operation and no extra resources available to pay-back existing debts.Headline Expenditure Projections Pharmaceuticals: EUR6.72bn (US$9.35bn) in 2011 to EUR5.92bn (US$7.52bn) in 2012; -12.0% in local currency terms and -19.6% in US dollar terms. Forecast broadly maintained from Q3 12. Healthcare: EUR21.80bn (US$30.31bn) in 2011 to EUR20.34bn (US$25.83bn) in 2012; -6.7% in local currency terms and -14.8% in US dollar terms. Forecast broadly stable from Q3 12. Medical devices: EUR670mn (US$931mn) in 2011 to EU607mn (US$771mn) in 2012; -9.3% in local currency terms and -17.1% in US dollar terms. Forecast unchanged from Q3 12. Risk/Reward Rating: In our latest RRRs, we have revised down our assessment of the Greek market, with a downgrade to the industry risk score as a result of broadly unfavourable operating conditions worsening, specifically re-payment terms, which we have criticised previously, and our assessment of whether innovative drugmakers would want to launch new products on the market.Competitive Landscape The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
The Pharmaceutical Market: Greece, Business Monitor International
Published on January 2013
Report Summary
Espicom market intelligence, brought to you by Business Monitor International
THE PHARMACEUTICAL MARKET: GREECE - REVIEW
The immediate threat of a Greek default and eurozone exit was reduced as the outcome of the legislative elections in June had a
much more benign outcome than many feared. A n exit would have - and could still be - disastrous for drugmakers operating in the
market. But even Greece staying in the monetary union means the government must continue with its austerity programme. While we
continue to hold to our view that Germany and the rest of the EU may reduce the focus on austerity and introduce some pro-growth
strategies, these are unlikely to generate any upside for the pharmaceutical industry and structural reforms within Greece will be
maintained. T he government remains committed to huge cuts in its public drug expenditure for 2012, with a painful claw-back tax in
operation and no extra resources available to pay-back existing debts.
Headline Expenditure Projections
Pharmaceuticals: EUR6.72bn (US$9.35bn) in 2011 to EUR5.92bn (US$7.52bn) in 2012;
-12.0% in local currency terms and -19.6% in US dollar terms. Forecast broadly maintained from Q3 12.
Healthcare: EUR21.80bn (US$30.31bn) in 2011 to EUR20.34bn (US$25.83bn) in 2012; -6.7% in local currency terms and -14.8% in
US dollar terms. Forecast broadly stable from Q3 12.
Medical devices: EUR670mn (US$931mn) in 2011 to EU607mn (US$771mn) in 2012; -9.3% in local currency terms and -17.1% in
US dollar terms. Forecast unchanged from Q3 12.
Risk/Reward Rating: In our latest RRRs, we have revised down our assessment of the Greek market, with a downgrade to the
industry risk score as a result of broadly unfavourable operating conditions worsening, specifically re-payment terms, which we have
criticised previously, and our assessment of whether innovative drugmakers would want to launch new products on the market.
Competitive Landscape
The competitive landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales -
for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
Table of Content
Table of Contents
BMI Industry View 7
The Pharmaceutical Market: Greece, Business Monitor International (From Slideshare) Page 1/5

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
SWOT 9
Political 11
Economic 12
Business Environment 13
Industry Forecast 14
Pharmaceutical Market Forecast 14
Table: Greece Pharmaceutical Sales, Historical Data And Forecasts 18
Healthcare Market Forecast 24
Table: Healthcare Expenditure Trends, Historical Data And Forecasts, 2009-2017 25
Table: Healthcare Governmental Indicators, 2009-2017 25
Table: Healthcare Private Indicators, 2009-2017 26
Economic Analysis 26
Prescription Drugs Market Forecast 32
Table: Prescription Drug Sales Indicators, 2009-2017 33
Patented Drugs Market Forecast 34
Table: Patented Drug Sales, 2009-2017 35
Generic Drugs Market Forecast 36
Table: Generic Drug Sales, 2009-2017 37
OTC Medicine Market Forecast 38
Table: OTC Medicine Sales, 2009-2017 39
Table: OTC Medicine Sales Breakdown, 2007-2010 39
Pharmaceutical Trade Forecast 40
Table: Pharmaceutical Trade Forecast, 2009-2017 41
Key Risks To BMI's Forecast Scenario 42
Industry Risk Reward Ratings 43
Table: Central And Eastern Europe Pharmaceutical Risk/Reward Ratings, Q113 43
Market Overview 47
Industry Trends And Developments 50
Epidemiology 50
Healthcare Sector 51
Infrastructure 53
Table: Inpatient Facilities And Beds By Speciality, 2008 54
Table: Outpatient Facilities And Beds By Region, 2008 55
Pharmaceutical Distribution 55
Drug Retailing 56
Table: Pharmacies By Region, 2007-2009 56
Regulatory Development 58
Regulatory Regime 58
Regional Strategy 58
Regulatory Regime 59
Intellectual Property Regime 60
Pricing Regime 61
Table: Quarterly Total Sales Volume Per Medicinal Product (additional to 9% of the current decision rebate amount) 65
Reimbursement Regime 66
Competitive Landscape 69
Company Profile 71
Vianex 71
Lavipharm 73
The Pharmaceutical Market: Greece, Business Monitor International (From Slideshare) Page 2/5

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Elpen 76
Genesis Pharma 78
Pharmathen 80
Kleva 82
Alapis Pharma 84
GlaxoSmithKline 87
Pfizer 89
Novartis 91
Sanofi 93
Table: Leading Products 94
Merck Sharpe & Dohme 95
Table: Merck Sharp & Dohme: Leading Products 96
Abbott Laboratories 97
Demographic Forecast 99
Greece Demographic Data 99
Table: Greece's Population By Age Group, 1990-2020 ('000) 100
Table: Greece's Population By Age Group, 1990-2020 (% of total) 101
Table: Greece's Key Population Ratios, 1990-2020 102
Table: Greece's Rural And Urban Population, 1990-2020 102
Methodology 103
Methodology 103
Risk/Reward Ratings Methodology 103
Ratings Overview 104
Table: Pharmaceutical Business Environment Indicators 104
Weighting 105
Table: Weighting Of Components 105
Sources 105
Glossary 106
The Pharmaceutical Market: Greece, Business Monitor International (From Slideshare) Page 3/5

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
The Pharmaceutical Market: Greece, Business Monitor International
Product Formats
Please select the product formats and the quantity you require.
1 User License--USD 1 397.25 Quantity: _____
Site License--USD 2 794.50 Quantity: _____
Corporate License--USD 8 383.50 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
The Pharmaceutical Market: Greece, Business Monitor International (From Slideshare) Page 4/5

5. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
The Pharmaceutical Market: Greece, Business Monitor International (From Slideshare) Page 5/5